Literature DB >> 28399683

KCNQ2-Associated Neonatal Epilepsy: Phenotype Might Correlate With Genotype.

Inn-Chi Lee1,2, Jiann-Jou Yang3, Jao-Shwann Liang4, Tung-Ming Chang5, Shuan-Yow Li2,3.   

Abstract

We analyzed the KCNQ2 wild-type gene and 3 mutations to highlight the important association between the KCNQ2 phenotype and genotype. The clinical phenotypes of 3 mutations (p.E515D, p.V543 M, and p.R213Q) were compared. KCNQ2, wild-type, and mutant KCNQ2 alleles were transfected into HEK293 cells before whole-cell patch-clamp analysis. Neurodevelopmental outcomes were worst in patients with the p.R213Q mutation, better in patients with the p.E515D mutation, and best in patients with the novel p.V543 M mutation. The currents in p.E515D and in p.V543 M were significantly lower than in the wild type in homomeric and heteromeric transfected HEK293 cells ( P < .05). The opening threshold shifted to values that were more positive, and the maximal current induced by strong depolarization was higher in cells with the p.E515D and p.R213Q mutations. We provide evidence that genotype is involved in determining clinical phenotype, including the seizure frequency and outcome.

Entities:  

Keywords:  KCNQ2; functional study; neonatal epilepsy; outcome; phenotype

Mesh:

Substances:

Year:  2017        PMID: 28399683     DOI: 10.1177/0883073817701873

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  KCNQ2 mutations in childhood nonlesional epilepsy: Variable phenotypes and a novel mutation in a case series.

Authors:  Inn-Chi Lee; Tung-Ming Chang; Jao-Shwann Liang; Shuan-Yow Li
Journal:  Mol Genet Genomic Med       Date:  2019-06-14       Impact factor: 2.183

2.  Clinical Study of 30 Novel KCNQ2 Variants/Deletions in KCNQ2-Related Disorders.

Authors:  Tiantian Xiao; Xiang Chen; Yan Xu; Huiyao Chen; Xinran Dong; Lin Yang; Bingbing Wu; Liping Chen; Long Li; Deyi Zhuang; Dongmei Chen; Yuanfeng Zhou; Huijun Wang; Wenhao Zhou
Journal:  Front Mol Neurosci       Date:  2022-04-26       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.